AHR
American Healthcare REIT, Inc.
NYSE · Real Estate · REIT - Healthcare Facilities · US
$55.22
−0.98%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.5B | 2.3B | 2.1B | 1.9B | 1.6B |
| Cost of Revenue | 2.1B | 1.8B | 1.7B | 1.5B | 1.3B |
| Gross Profit | 373.8M | 466.6M | 416.8M | 356.8M | 336.0M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 37.6B | 110.2M | 100.8M | 105.0M | 103.1M |
| General & Admin Expense | 37.6B | 110.2M | 100.8M | 105.0M | 103.1M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | (37.4B) | 187.6M | 179.2M | 175.1M | 142.3M |
| Total Operating Expenses | 205.1M | 297.7M | 280.0M | 280.1M | 245.4M |
| Cost and Expenses | 2.3B | 2.1B | 1.9B | 1.8B | 1.5B |
| Operating Income (EBIT) | 168.7M | 168.9M | 136.8M | 76.7M | 90.6M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 77.6M | 85.8M | 127.7M | 163.2M | 106.0M |
| Net Interest Income | (77.6M) | (85.8M) | (127.7M) | (163.2M) | (106.0M) |
| Other Non-Op Income/Expense | (70.1M) | (120.2M) | (170.7M) | (152.9M) | (163.4M) |
| Non-Operating Income (excl Interest) | (7.5M) | 34.4M | 42.9M | (10.2M) | 57.4M |
| EBT (Pre-Tax Income) | 98.5M | 48.6M | (33.9M) | (76.2M) | (72.8M) |
| Income Tax Expense | (24.0M) | (22.2M) | 1.7M | 663.0K | 586.0K |
| Bottom Line | |||||
| Net Income | 121.0M | 69.8M | (37.8M) | (71.5M) | (81.3M) |
| Earnings from Cont. Ops | 122.6M | 70.8M | (35.6M) | (76.9M) | (73.4M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 121.0M | 69.8M | (37.8M) | (71.5M) | (81.3M) |
| Per Share | |||||
| Basic EPS | $0.68 | $0.42 | ($0.29) | ($1.08) | ($1.23) |
| Diluted EPS | $0.68 | $0.42 | ($0.29) | ($1.08) | ($1.23) |
| Revenue Per Share | $13.17 | $13.61 | $15.85 | $28.15 | $24.43 |
| Shares | |||||
| Basic Shares Outstanding | 190.0M | 166.1M | 130.6M | 66.0M | 66.2M |
| Diluted Shares Outstanding | 190.7M | 166.8M | 130.6M | 66.0M | 66.2M |
| Profitability Metrics | |||||
| EBITDA | 447.2M | 359.6M | 315.5M | 324.3M | 233.8M |
| D&A | 271.0M | 225.2M | 221.6M | 237.3M | 200.6M |
| EBIT | 176.2M | 134.4M | 93.8M | 87.0M | 33.2M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026